$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$7.28B
Market Cap
13.2
P/E Ratio
4.69
EPS
$79.50
52 Week High
$46.26
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Halozyme Therapeutics, Inc. is an innovative biopharmaceutical company headquartered in San Diego, California, recognized for its groundbreaking drug delivery technologies that significantly enhance the effectiveness of existing therapies. Utilizing its proprietary ENHANZE® technology, Halozyme focuses on developing subcutaneous formulations that improve patient adherence and outcomes across a range of indications. The company strategically collaborates with industry-leading pharmaceutical partners, thereby expanding its therapeutic offerings and solidifying its role as a key player in the biotechnology sector. With a global operational footprint in the U.S., Europe, and Asia, Halozyme is well-positioned to meet the growing demand for more effective and patient-friendly therapeutic solutions.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
DNN
F
PLTD
AAL
HPE
KVUE
WULF
MARA
PLTR
VALE
BYND
BAC
RR
APLT
SNAP
CLSK
BITF
GOOGL
IRBT
IREN
IVP
PFE
RIG
RKLB
QBTS
NIO
CIFR
NFLX
ASBP
AMD
GRAB
SMR
MTSR
FI
WBD
HOOD
HL
JBLU
APLD
CAN
SOUN
CDE
T
AG
BTBT
HBAN
DVLT
NOK
EOSE
GOOG
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
DNN
F
PLTD
AAL
HPE
KVUE
WULF
MARA
PLTR
VALE
BYND
BAC
RR
APLT
SNAP
CLSK
BITF
GOOGL
IRBT
IREN
IVP
PFE
RIG
RKLB
QBTS
NIO
CIFR
NFLX
ASBP
AMD
GRAB
SMR
MTSR
FI
WBD
HOOD
HL
JBLU
APLD
CAN
SOUN
CDE
T
AG
BTBT
HBAN
DVLT
NOK
EOSE
GOOG